Hidradenitis Suppurativa Treatment: A Complete Guide

Medication
Topical Creams
Biologics and Biosimilars
- adalimumab (Humira Pen or syringe)
- secukinumab (Cosentyx)
- bimekizumab-bkzx (Bimzelx)
Infliximab (Remicade), though not approved, is sometimes used to reduce symptoms and inflammation.
- adalimumab-ryvk (Simlandi)
- adalimumab-aaty (Yuflyma)
- adalimumab-aacf (Idacio)
- adalimumab-aqvh (Yusimry)
- adalimumab-fkjp (Hulio)
- adalimumab-afzb (Abrilada)
Off-Label Oral Medications
Antibiotics
- clindamycin (Cleocin HCl, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage)
- rifampin (Rifadin, Rifadin IV, Rimactane)
- doxycycline (Vibramycin, Acticlate, Adoxa)
- minocycline (Minocin, Dynacin, Minocin, Minocin PAC, Minolira)
Corticosteroids
Hormonal Therapy
- estrogen birth control pills
- ethinylestradiol/cyproterone acetate (Diane, Diane-35)
- metformin (Fortamet, Glucophage, Glucophage XR) is not a hormone but does affect hormones
These medications may come with a variety of side effects. If you notice any new symptoms after beginning a medication, let your healthcare provider know right away.
Other Treatment Options
- isotretinoin (Absorica, Absorica LD, Accutane)
- acitretin (Soriatane)
Surgery and Procedures
Lifestyle Changes
Certain lifestyle changes can help your HS treatment work better, relieve symptoms, and prevent flares.
Pain Management
Mental Health
You can find information and support through these organizations:
The Takeaway
- Hidradenitis suppurativa (HS), a chronic skin condition that appears after puberty and lasts many years, causes painful bumps under the skin and scarring on the skin’s surface.
- While there is no cure for HS, the condition can be treated with creams, anti-inflammatory oral medications, and in more severe cases, surgery and certain procedures.
- Other lifestyle changes like careful skin care, weight management, and keeping your skin dry can help prevent flare-ups.
- Work closely with your healthcare provider to manage treatment and monitor affected areas of your skin.

Jacquelyn Dosal, MD
Medical Reviewer
Jacquelyn Dosal, MD, is a board-certified dermatologist practicing at The Dermatology House in Park City, Utah. Her areas of expertise include acne, rosacea, integrative treatments of inflammatory skin diseases, as well as laser treatment of the skin and injectables.
Dr. Dosal writes cosmetic questions for the certifying exams for the American Board of Dermatology. She is also the deputy editor for the American Academy of Dermatology's podcast, Dialogues in Dermatology.

Abby McCoy, RN
Author
Abby McCoy is an experienced registered nurse who has worked with adults and pediatric patients encompassing trauma, orthopedics, home care, transplant, and case management. She is a married mother of four and loves the circus — that is her home! She has family all over the world, and loves to travel as much as possible.
McCoy has written for publications like Remedy Health Media, Sleepopolis, and Expectful. She is passionate about health education and loves using her experience and knowledge in her writing.
- Ludmann P. Hidradenitis Suppurativa: Overview. American Academy of Dermatology Association. May 3, 2022.
- Hidradenitis Suppurativa (HS): Diagnosis, Treatment, and Steps to Take. National Institute of Arthritis and Musculoskeletal and Skin Diseases. June 2022.
- Frew JW et al. Topical, Systemic and Biologic Therapies in Hidradenitis Suppurativa: Pathogenic Insights by Examining Therapeutic Mechanisms. Therapeutic Advances in Chronic Disease. March 2019.
- Ludmann P. Hidradenitis Suppurativa: Diagnosis and Treatment. American Academy of Dermatology Association. July 22, 2024.
- Clindamycin (Topical Route). Mayo Clinic. September 1, 2024.
- Molinelli E et al. Efficacy and Safety of Topical Resorcinol 15% Versus Topical Clindamycin 1% in the Management of Mild‐to‐Moderate Hidradenitis Suppurativa: A Retrospective Study. Dermatologic Therapy. June 2022.
- Resorcinol (Topical Route). Mayo Clinic. February 1, 2024.
- Rath L. Biologics. Arthritis Foundation. September 3, 2022.
- Medication Guide. U.S. Food and Drug Administration.
- Highlights of Prescribing Information: Humira. U.S. Food and Drug Administration. September 2024.
- Highlights of Prescribing Information: Bimzelx. U.S. Food and Drug Administration. September 2024.
- Bemt BJ et al. A Portfolio of Biologic Self-Injection Devices in Rheumatology: How Patient Involvement in Device Design Can Improve Treatment Experience. Drug Delivery. March 2019.
- Lipa K et al. Hidradenitis Suppurativa – Biologic Therapy and Other Available Treatment Options. Advances in Dermatology and Allergology. August 2023.
- Perry T. Biosimilars or Biologics: What’s the Difference? Therapeutics Letter. October 2019.
- Biosimilar Product Information. U.S. Food and Drug Administration.
- Psoriasis Treatment: Biologics. American Academy of Dermatology Association. August 22, 2024.
- Biosimilar and Interchangeable Biologics: More Treatment Choices. U.S. Food and Drug Administration. August 17, 2023.
- Nesbitt E et al. A Concise Clinician’s Guide to Therapy for Hidradenitis Suppurativa. International Journal of Women's Dermatology. March 2020.
- Hidradenitis Suppurativa. Cleveland Clinic. December 20, 2022.
- Clindamycin (Oral Route). Mayo Clinic. September 1, 2024.
- Rifampin (Oral Route). Mayo Clinic. September 1, 2024.
- Minocycline (Oral Route). Mayo Clinic. May 1, 2024.
- Doxycycline (Oral Route). Mayo Clinic. September 1, 2024.
- Erlendsson AM et al. Intermittent Low-Dose Corticosteroid Therapy for Hidradenitis Suppurativa: A Case Series. JAAD Case Reports. July 2021.
- Prednisone and Other Corticosteroids. Mayo Clinic. December 9, 2022.
- Corticosteroids. Arthritis Foundation.
- Rached NA et al. The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review. International Journal of Molecular Sciences. December 2023.
- Rosenberg J. Researchers Outline Use of Hormonal Therapies in Acne, Hidradenitis Suppurativa. The American Journal of Managed Care. June 25, 2022.
- Karagaiah P et al. Update on Hormonal Therapy in Hidradenitis Suppurativa. Journal of Drugs in Dermatology. April 2023.
- Molinelli E et al. Efficacy of Oral Zinc and Nicotinamide as Maintenance Therapy for Mild/Moderate Hidradenitis Suppurativa: A Controlled Retrospective Clinical Study. Journal of the American Academy of Dermatology. August 2020.
- Rabinovich D et al. Zinc. StatPearls. May 1, 2023.
- Molinelli E et al. Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review. Dermatology and Therapy. May 2024.
- Hidradenitis Suppurativa. Mayo Clinic. June 21, 2024.
- Shukla R et al. Surgical Treatment in Hidradenitis Suppurativa. Journal of Clinical Medicine. May 2022.
- Mansour MR et al. Punch Debridement (Mini-Deroofing): An In-Office Surgical Option for Hidradenitis Suppurativa. Journal of the American Academy of Dermatology. June 2024.
- Saylor DK et al. Office-Based Surgical Intervention for Hidradenitis Suppurativa (HS): A Focused Review for Dermatologists. Dermatology and Therapy. August 2020.
- García-Martínez FJ et al. Intralesional Corticosteroid Injection for the Treatment of Hidradenitis Suppurativa: A Multicenter Retrospective Clinical Study. Journal of Dermatological Treatment. May 2021.
- Clark SR et al. Effectiveness of Surgical Deroofing and Carbon Dioxide Laser in Moderate-to-Severe Hidradenitis Suppurativa Patients. Cureus. March 2024.
- Shipman WD et al. Efficacy of Laser Hair Removal in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis. Lasers in Surgery and Medicine. July 2024.
- What Is the Glycemic Index? Cleveland Clinic. October 21, 2021.
- Hidradenitis Suppurativa. Cedars-Sinai.
- Ludmann P. Hidradenitis Suppurativa: Self-Care. American Academy of Dermatology Association. May 3, 2022.
- Hidradenitis Suppurativa. British Association of Dermatologists. May 2024.
- Ballard K et al. Hidradenitis Suppurativa. StatPearls. May 6, 2024.
- Healthy Weight Control. National Institutes of Health. December 2022.
- Mokos ZB et al. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerologica Croatica. July 2020.
- Quit Smoking. American Lung Association.
- Richards E et al. Psychosocial Effects of Hidradenitis Suppurativa in the Literature: A Systematic Review. International Journal of Psychiatry in Medicine. April 21, 2024.
- Depression. National Institute of Mental Health. March 2024.
- Anxiety. National Institute of Mental Health. April 2024.
- Akyirem S et al. Psychosocial Interventions for Adults With Newly Diagnosed Chronic Disease: A Systematic Review. Journal of Health Psychology. June 2022.